The global pharmaceutical industry is witnessing rapid advancements in processes and technology development, with automation emerging as an integral part of most manufacturing processes. Due to the implementation of stringent regulatory norms and spiraling costs, pharmaceutical companies are opting to outsource their manufacturing process to contract manufacturing organizations in order to improve efficiency and productivity. As per our new research report “Global Contract Manufacturing Market Analysis”, the pharmaceutical contract manufacturing market is expected to grow at a CAGR of around 12% during 2010-2012.
We have found that countries like India, Brazil, Ukraine, Mexico, China and Singapore have been emerging as the key destination for contract manufacturing. Several factors like low cost of manufacturing and highly developed infrastructure have boosted growth in the contract manufacturing industry. Our report provides complete analysis and information about the contract manufacturing industry of respective countries.
The key industry trends like biomanufacturing and changing quality procedures have been studied in the report. It is expected that these trends will drive the overall industry in future. We have found that pharmaceutical companies are increasingly adopting the concept of ‘virtual pharma’, wherein they retain the marketing rights while outsourcing all manufacturing activities and related processes. This allows companies to deliver goods at a faster rate than an internal plant would allow.
“Global Contract Manufacturing Market Analysis” provides extensive research and prudent analysis of the global contract manufacturing industry. It studies the past and present market trends to enable clients understand the market dynamics and opportunities for the expansion of business. The report highlights key industry issues and presents an unbiased picture of the industry. The report also includes information about the major players along with their business strategies at the country level markets. Thus, the report could be very valuable for investors while taking decision on investments.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM265.htm